| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |